Hematology | Topics

Ginzburg Discusses Most Interesting Presentations From ASH 2021
January 11, 2022

At the 2021 ASH Annual Meeting, Yelena Ginzburg, MD, spoke about presentations she found most groundbreaking.

Storing Red Blood Cells in a Hypoxic State vs Normoxia Could Lower Adhesion
January 07, 2022

Investigators believe that storing red blood cells in a hypoxic state could reduce the development of vaso-occlusion flowing transfusion.

aGVHD Incidence Following HSCT May be Reduced Following Treatment With Itolizumab
January 03, 2022

Patients receiving hematopoietic stem cell transplantation appeared to have improved outcomes and a decreased incidence of acute graft-versus-host disease after being treated with itolizumab.

Amphiregulin Appears to be a Promising Predictive Marker for Mortality in Acute Graft-Versus-Host Disease
December 29, 2021

Patients who have been diagnosed with acute graft-versus-host disease with high levels of amphiregulin could be at a higher risk for early mortality.

Recap: Experts Review Management of Chronic GVHD
December 25, 2021

Recommendations for treating patients with steroid-refractory chronic GVHD based on evidence demonstrated by the REACH3 trial.

Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab
December 22, 2021

Rituximab-subcutaneously is associated with significantly reduced chair time vs rituximab-intravenously in a US oncology setting. Widespread adoption would be expected to improve practice efficiency and patient access to care, and to reduce health care resource burden.

FDA Approves Abatacept as a Preventative Treatment for Acute Graft-Versus-Host Disease
December 15, 2021

Abatacept can now be used for the prevention of acute graft-versus-host disease following its approval by the FDA.

Psychological Distress Impacts How Patients With Hematologic Cancers Perceive Clinical Cancer Studies
December 12, 2021

Depression and anxiety notably impact how patients with hematologic malignancies view clinical studies.

Link Established Between Active Disease/ICU Deferral and COVID-19 Mortality in AML, ALL, and MDS
December 12, 2021

Investigators noted that patients with acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndrome who were diagnosed with COVID-19 were more likely to experience COVID-19 mortality vs non-cancer patients.

Orca-T Improves Outcomes Over Standard of Care for Serious Hematologic Malignancies
December 11, 2021

Orca-T improved efficacy outcomes over standard of care therapy for patients with serious hematologic malignancies.